Research progress on the mechanism of organ-specific lung metastasis in pancreatic cancer

Ming YUE; Liwei WANG; Jiujie CUI

doi:10.19401/j.cnki.1007-3639.2023.11.008

您当前的位置：

首页 >

文章列表页 >

Research progress on the mechanism of organ-specific lung metastasis in pancreatic cancer

Review | 更新时间：2025-12-31

- Research progress on the mechanism of organ-specific lung metastasis in pancreatic cancer
- China Oncology Vol. 33, Issue 11, Pages: 1026-1031(2023)
- 作者机构：
  
  上海交通大学医学院附属仁济医院肿瘤科，上海 200127
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2023.11.008
  CLC： R735.9
- Received：03 May 2023，
  
  Revised：2023-07-03，
  
  Published：30 November 2023
- 稿件说明：
移动端阅览
Ming YUE, Liwei WANG, Jiujie CUI. Research progress on the mechanism of organ-specific lung metastasis in pancreatic cancer[J]. China Oncology, 2023, 33(11): 1026-1031.
DOI：

Ming YUE, Liwei WANG, Jiujie CUI. Research progress on the mechanism of organ-specific lung metastasis in pancreatic cancer[J]. China Oncology, 2023, 33(11): 1026-1031. DOI： 10.19401/j.cnki.1007-3639.2023.11.008.

摘要

胰腺癌是一种高度恶性的消化系统肿瘤，由于早期无特异性的临床症状，其早期诊断非常困难，几乎一半的胰腺癌患者在初次确诊时已经发生了远处转移，转移性胰腺癌的生物学特性研究尤为重要。近年来，胰腺癌的器官特异性转移受到了广泛关注，胰腺癌肺转移患者表现出显著的生存优势。与其他部位转移相比，胰腺癌肺转移在基因表达、肿瘤微环境及肿瘤干细胞等多个方面也存在显著差异。本文对胰腺癌器官特异性肺转移机制的研究进展进行综述。

Abstract

Pancreatic cancer is a highly malignant tumor of the digestive system. Due to the non-specific clinical symptoms in the early stage

its early diagnosis is very difficult. Almost half of the patients with pancreatic cancer have already developed distant metastases at the time of initial diagnosis. In recent years

organ-specific metastasis of pancreatic cancer has received extensive attention. Patients with lung metastasis of pancreatic cancer have shown significant survival benefits. Compared with other metastatic sites

lung metastasis of pancreatic cancer also shows significant differences in gene expression

tumor microenvironment

tumor stem cells and other aspects. This review summarized the research progress on the mechanism of organ-specific lung metastasis in pancreatic cancer.

关键词

Keywords

references

SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . DOI: 10.3322/caac.v71.3 http://doi.org/10.3322/caac.v71.3 https://acsjournals.onlinelibrary.wiley.com/toc/15424863/71/3 https://acsjournals.onlinelibrary.wiley.com/toc/15424863/71/3

CAO W , CHEN H D , YU Y W , et al . Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020 [J ] . Chin Med J (Engl) , 2021 , 134 ( 7 ): 783 - 791 .

MIZRAHI J D , SURANA R , VALLE J W , et al . Pancreatic cancer [J ] . Lancet , 2020 , 395 ( 10242 ): 2008 - 2020 . DOI: S0140-6736(20)30974-0 http://doi.org/S0140-6736(20)30974-0

SIEGEL R L , MILLER K D , FUCHS H E , et al . Cancer statistics, 2022 [J ] . CA Cancer J Clin , 2022 , 72 ( 1 ): 7 - 33 . DOI: 10.3322/caac.v72.1 http://doi.org/10.3322/caac.v72.1 https://acsjournals.onlinelibrary.wiley.com/toc/15424863/72/1 https://acsjournals.onlinelibrary.wiley.com/toc/15424863/72/1

SPRINGFELD C , JAGER D , BUCHLER M W , et al . Chemotherapy for pancreatic cancer [J ] . Presse Med , 2019 , 48 ( 3 ): E159 -E174. DOI: 10.1016/j.lpm.2019.02.025 http://doi.org/10.1016/j.lpm.2019.02.025 https://linkinghub.elsevier.com/retrieve/pii/S0755498219300740 https://linkinghub.elsevier.com/retrieve/pii/S0755498219300740

KRUGER S , HAAS M , BURGER P J , et al . Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer [J ] . Pancreatology , 2016 , 16 ( 4 ): 593 - 598 . DOI: 10.1016/j.pan.2016.03.016 http://doi.org/10.1016/j.pan.2016.03.016

KAMISAWA T , ISAWA T , KOIKE M , et al . Hematogenous metastases of pancreatic ductal carcinoma [J ] . Pancreas , 1995 , 11 ( 4 ): 345 - 349 . DOI: 10.1097/00006676-199511000-00005 http://doi.org/10.1097/00006676-199511000-00005 http://journals.lww.com/00006676-199511000-00005 http://journals.lww.com/00006676-199511000-00005

YACHIDA S , IACOBUZIO-DONAHUE C A . The pathology and genetics of metastatic pancreatic cancer [J ] . Arch Pathol Lab Med , 2009 , 133 ( 3 ): 413 - 422 . DOI: 10.1043/1543-2165-133.3.413 http://doi.org/10.1043/1543-2165-133.3.413

HO W J , ERBE R , DANILOVA L , et al . Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways [J ] . Genome Biol , 2021 , 22 ( 1 ): 154 . DOI: 10.1186/s13059-021-02363-6 http://doi.org/10.1186/s13059-021-02363-6

OETTLE H , NEUHAUS P , HOCHHAUS A , et al . Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial [J ] . JAMA , 2013 , 310 ( 14 ): 1473 - 1481 . DOI: 10.1001/jama.2013.279201 http://doi.org/10.1001/jama.2013.279201

SINN M , BAHRA M , LIERSCH T , et al . CONKO-005: adjuvant chemotherapy with gemcitabine plus erlotinib versus gemcitabine alone in patients after R0 resection of pancreatic cancer: a multicenter randomized phase Ⅲ trial [J ] . J Clin Oncol , 2017 , 35 ( 29 ): 3330 - 3337 . DOI: 10.1200/JCO.2017.72.6463 http://doi.org/10.1200/JCO.2017.72.6463 https://ascopubs.org/doi/10.1200/JCO.2017.72.6463 https://ascopubs.org/doi/10.1200/JCO.2017.72.6463

SINN M , LIERSCH T , RIESS H , et al . CONKO-006: a randomised double-blinded phase Ⅱb-study of additive therapy with gemcitabine+sorafenib/placebo in patients with R1 resection of pancreatic cancer-final results [J ] . Eur J Cancer , 2020 , 138 : 172 - 181 . DOI: 10.1016/j.ejca.2020.06.032 http://doi.org/10.1016/j.ejca.2020.06.032 https://linkinghub.elsevier.com/retrieve/pii/S0959804920303658 https://linkinghub.elsevier.com/retrieve/pii/S0959804920303658

KURRECK A , WECKWERTH J , MODEST D P , et al . Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma-a pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials [J ] . Eur J Cancer , 2021 , 150 : 250 - 259 . DOI: 10.1016/j.ejca.2021.03.036 http://doi.org/10.1016/j.ejca.2021.03.036 https://linkinghub.elsevier.com/retrieve/pii/S0959804921002033 https://linkinghub.elsevier.com/retrieve/pii/S0959804921002033

NEOPTOLEMOS J P , PALMER D H , GHANEH P , et al . Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial [J ] . Lancet , 2017 , 389 ( 10073 ): 1011 - 1024 . DOI: S0140-6736(16)32409-6 http://doi.org/S0140-6736(16)32409-6

KIM S , ITCHINS M , ARENA J , et al . Patterns and determinants of recurrence for pancreatic ductal adenocarcinoma after resection [J ] . J Pancreas . 2017 , 18 ( 6 ): 458 - 464 .

LIU K H , HUNG C Y , HSUEH S W , et al . Lung metastases in patients with stage Ⅳ pancreatic cancer: prevalence, risk factors, and survival impact [J ] . J Clin Med , 2019 , 8 ( 9 ): E1402 .

GUERRA F , BARUCCA V , COLETTA D . Metastases or primary recurrence to the lung is related to improved survival of pancreatic cancer as compared to other sites of dissemination. Results of a systematic review with meta-analysis [J ] . Eur J Surg Oncol , 2020 , 46 (10 Pt A): 1789 - 1794 . DOI: S0748-7983(20)30533-3 http://doi.org/S0748-7983(20)30533-3

KRUGER S F , LOHNEIS A , ABENDROTH A , et al . Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study [J ] . ESMO Open , 2022 , 7 ( 1 ): 100388 . DOI: 10.1016/j.esmoop.2022.100388 http://doi.org/10.1016/j.esmoop.2022.100388 https://linkinghub.elsevier.com/retrieve/pii/S2059702922000084 https://linkinghub.elsevier.com/retrieve/pii/S2059702922000084

BUSCAIL E , CHAUVET A , QUINCY P , et al . CD63-GPC1-positive exosomes coupled with CA19-9 offer good diagnostic potential for resectable pancreatic ductal adenocarcinoma [J ] . Transl Oncol , 2019 , 12 ( 11 ): 1395 - 1403 . DOI: S1936-5233(19)30180-9 http://doi.org/S1936-5233(19)30180-9

KÜNZLI B M , BERBERAT P O , ZHU Z W W , et al . Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma [J ] . Cancer , 2002 , 94 ( 1 ): 228 - 239 .

LI M , WU X D , LIU N , et al . Silencing of ATF2 inhibits growth of pancreatic cancer cells and enhances sensitivity to chemotherapy [J ] . Cell Biol Int , 2017 , 41 ( 6 ): 599 - 610 . DOI: 10.1002/cbin.10760 http://doi.org/10.1002/cbin.10760

JEON Y H , HA M , KIM S W , et al . Evaluation of the prognostic significances of γ-secretase genes in pancreatic cancer [J ] . Oncol Lett , 2019 , 17 ( 5 ): 4614 - 4620 . DOI: 10.3892/ol.2019.10113 http://doi.org/10.3892/ol.2019.10113

FERGUSON M D , DONG L , WAN J , et al . Molecular alterations associated with DNA repair in pancreatic adenocarcinoma are associated with sites of recurrence [J ] . J Gastrointest Cancer , 2019 , 50 ( 2 ): 285 - 291 . DOI: 10.1007/s12029-018-0073-8 http://doi.org/10.1007/s12029-018-0073-8

FORMICA V , DOLDO E , ANTONETTI F R , et al . Biological and predictive role of ERCC1 polymorphisms in cancer [J ] . Crit Rev Oncol Hematol , 2017 , 111 : 133 - 143 . DOI: S1040-8428(16)30262-1 http://doi.org/S1040-8428(16)30262-1

ULKER M , DUMAN B B , SAHIN B , et al . ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine [J ] . Contemp Oncol (Pozn) , 2015 , 19 ( 3 ): 207 - 213 .

LIU Y , CAO X . Characteristics and significance of the pre-metastatic niche [J ] . Cancer Cell , 2016 , 30 ( 5 ): 668 - 681 . DOI: S1535-6108(16)30446-9 http://doi.org/S1535-6108(16)30446-9

ARMACKI M , POLASCHEK S , WALDENMAIER M , et al . Protein kinase D1, reduced in human pancreatic tumors, increases secretion of small extracellular vesicles from cancer cells that promote metastasis to lung in mice [J ] . Gastroenterology , 2020 , 159 ( 3 ): 1019 - 1035 .e22. DOI: S0016-5085(20)34705-3 http://doi.org/S0016-5085(20)34705-3

GRÜNWALD B , HARANT V , SCHATEN S , et al . Pancreatic premalignant lesions secrete tissue inhibitor of metalloproteinases-1, which activates hepatic stellate cells via CD63 signaling to create a premetastatic niche in the liver [J ] . Gastroenterology , 2016 , 151 ( 5 ): 1011 - 1024 .e7. DOI: 10.1053/j.gastro.2016.07.043 http://doi.org/10.1053/j.gastro.2016.07.043 https://linkinghub.elsevier.com/retrieve/pii/S0016508516348909 https://linkinghub.elsevier.com/retrieve/pii/S0016508516348909

WANG Y , LIANG Y Y , XU H Y , et al . Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response [J ] . Cell Discov , 2021 , 7 ( 1 ): 36 . DOI: 10.1038/s41421-021-00271-4 http://doi.org/10.1038/s41421-021-00271-4

XIAO Q , ZHOU D E , RUCKI A A , et al . Cancer-associated fibroblasts in pancreatic cancer are reprogrammed by tumor-induced alterations in genomic DNA methylation [J ] . Cancer Res , 2016 , 76 ( 18 ): 5395 - 5404 . DOI: 10.1158/0008-5472.CAN-15-3264 http://doi.org/10.1158/0008-5472.CAN-15-3264

PAN X Y , ZHOU J J , XIAO Q , et al . Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma [J ] . J Hematol Oncol , 2021 , 14 ( 1 ): 184 . DOI: 10.1186/s13045-021-01203-1 http://doi.org/10.1186/s13045-021-01203-1

SASAKI T , NISHIWADA S , NAKAGAWA K , et al . Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer [J ] . Int J Clin Oncol , 2022 , 27 ( 5 ): 948 - 957 . DOI: 10.1007/s10147-022-02131-x http://doi.org/10.1007/s10147-022-02131-x

HERMANN P C , HUBER S L , HERRLER T , et al . Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer [J ] . Cell Stem Cell , 2007 , 1 ( 3 ): 313 - 323 . DOI: 10.1016/j.stem.2007.06.002 http://doi.org/10.1016/j.stem.2007.06.002

LI C W , HEIDT D G , DALERBA P , et al . Identification of pancreatic cancer stem cells [J ] . Cancer Res , 2007 , 67 ( 3 ): 1030 - 1037 . DOI: 10.1158/0008-5472.CAN-06-2030 http://doi.org/10.1158/0008-5472.CAN-06-2030

NIMMAKAYALA R K , LEON F , RACHAGANI S , et al . Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma [J ] . Oncogene , 2021 , 40 ( 1 ): 215 - 231 . DOI: 10.1038/s41388-020-01518-2 http://doi.org/10.1038/s41388-020-01518-2

LU W , KANG Y B . Epithelial-mesenchymal plasticity in cancer progression and metastasis [J ] . Dev Cell , 2019 , 49 ( 3 ): 361 - 374 . DOI: S1534-5807(19)30280-1 http://doi.org/S1534-5807(19)30280-1

REYNOLDS A B , ROCZNIAK-FERGUSON A . Emerging roles for p120-catenin in cell adhesion and cancer [J ] . Oncogene , 2004 , 23 ( 48 ): 7947 - 7956 . DOI: 10.1038/sj.onc.1208161 http://doi.org/10.1038/sj.onc.1208161

REICHERT M , BAKIR B , MOREIRA L , et al . Regulation of epithelial plasticity determines metastatic organotropism in pancreatic cancer [J ] . Dev Cell , 2018 , 45 ( 6 ): 696 - 711 .e8. DOI: S1534-5807(18)30418-0 http://doi.org/S1534-5807(18)30418-0

Views

1533

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

A research on the mechanism of SERPINA3 promoting malignant progression and gemcitabine resistance of pancreatic cancer by inhibiting ferroptosis

Effect of liposome binding antisense oligonucleotide BP1003 on albumin-bound paclitaxel sensitivity in pancreatic cancer cells by inhibiting STAT3

New advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2024

An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer

Research on uPAR promoting proliferation, migration, and chemoresistance of pancreatic cancer by inhibiting autophagy via MAPK signaling

Related Author

Yuan HE

Juncheng GUO

Zhibin YE

Xiaohu WANG

Haonan LI

Jingbiao HUANG

Hua FU

Guochao ZHOU

Related Institution

Department of Gastrointestial Surgery, Hebei General Hospital

The First Clinical College of Changzhi Medical College

Department of Gastrointestial Surgery, Heping Hospital Affiliated to Changzhi Medical College

Department of Hepatology and Gallbladder, Xiangxi Autonomous Prefecture People’s Hospital, Xiangxi

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai Pancreatic Cancer Institute, Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Pancreatic Cancer Institute, Fudan University

AI问答

⁰